Matches in SemOpenAlex for { <https://semopenalex.org/work/W2006996657> ?p ?o ?g. }
- W2006996657 endingPage "3425" @default.
- W2006996657 startingPage "3419" @default.
- W2006996657 abstract "Abstract We designed a phase 1-2 study to evaluate the safety and the efficacy of increasing doses of bendamustine (160 mg/m2, 180 mg/m2, and 200 mg/m2 given on days −7 and −6) coupled with fixed doses of etoposide, cytarabine, and melphalan (BeEAM regimen) as the conditioning regimen to autologous stem cell transplantation for resistant/relapsed lymphoma patients. Forty-three patients (median age, 47 years) with non-Hodgkin (n = 28) or Hodgkin (n = 15) lymphoma were consecutively treated. Nine patients entered the phase 1 study; no patients experienced a dose-limiting toxicity. Thirty-four additional patients were then treated in the phase 2. A median number of 6 × 106 CD34+ cells/kg (range, 2.4-15.5) were reinfused. All patients engrafted, with a median time to absolute neutrophil count > 0.5 × 109/L of 10 days. The 100-day transplantation-related mortality was 0%. After a median follow-up of 18 months, 35 of 43 patients (81%) are in complete remission, whereas 6 of 43 relapsed and 2 of 43 did not respond. Disease type (non-Hodgkin lymphomas vs Hodgkin disease) and disease status at transplantation (chemosensitive vs chemoresistant) significantly influenced DFS (P = .01; P = .007). Remarkably, 4 of 43 (9%) patients achieved the first complete remission after receiving the high-dose therapy with autologous stem cell transplantation. In conclusion, the new BeEAM regimen is safe and effective for heavily pretreated lymphoma patients. The study was registered at European Medicines Agency (EudraCT number 2008-002736-15)." @default.
- W2006996657 created "2016-06-24" @default.
- W2006996657 creator A5008693201 @default.
- W2006996657 creator A5012491961 @default.
- W2006996657 creator A5016570572 @default.
- W2006996657 creator A5022200573 @default.
- W2006996657 creator A5028913158 @default.
- W2006996657 creator A5030759518 @default.
- W2006996657 creator A5042609656 @default.
- W2006996657 creator A5045852022 @default.
- W2006996657 creator A5051903959 @default.
- W2006996657 creator A5057593886 @default.
- W2006996657 creator A5061282516 @default.
- W2006996657 creator A5066257986 @default.
- W2006996657 creator A5068687462 @default.
- W2006996657 creator A5070417705 @default.
- W2006996657 creator A5078922292 @default.
- W2006996657 creator A5080860305 @default.
- W2006996657 creator A5081280217 @default.
- W2006996657 creator A5081703894 @default.
- W2006996657 creator A5082045927 @default.
- W2006996657 creator A5086831338 @default.
- W2006996657 date "2011-09-22" @default.
- W2006996657 modified "2023-10-12" @default.
- W2006996657 title "BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients" @default.
- W2006996657 cites W1511417912 @default.
- W2006996657 cites W1541287496 @default.
- W2006996657 cites W1822252547 @default.
- W2006996657 cites W1970990886 @default.
- W2006996657 cites W1974312523 @default.
- W2006996657 cites W1980203391 @default.
- W2006996657 cites W1997241992 @default.
- W2006996657 cites W1997353354 @default.
- W2006996657 cites W2013243341 @default.
- W2006996657 cites W2021698749 @default.
- W2006996657 cites W2040298958 @default.
- W2006996657 cites W2053978875 @default.
- W2006996657 cites W2057456103 @default.
- W2006996657 cites W2059524199 @default.
- W2006996657 cites W2060142613 @default.
- W2006996657 cites W2063553062 @default.
- W2006996657 cites W2063591291 @default.
- W2006996657 cites W2077407285 @default.
- W2006996657 cites W2077945404 @default.
- W2006996657 cites W2079433846 @default.
- W2006996657 cites W2094333196 @default.
- W2006996657 cites W2103563361 @default.
- W2006996657 cites W2113961586 @default.
- W2006996657 cites W2120755425 @default.
- W2006996657 cites W2122654415 @default.
- W2006996657 cites W2127971712 @default.
- W2006996657 cites W2128936398 @default.
- W2006996657 cites W2131998596 @default.
- W2006996657 cites W2133201432 @default.
- W2006996657 cites W2138480544 @default.
- W2006996657 cites W2138786695 @default.
- W2006996657 cites W2141164659 @default.
- W2006996657 cites W2142019712 @default.
- W2006996657 cites W2150587745 @default.
- W2006996657 cites W2157717016 @default.
- W2006996657 cites W2178468906 @default.
- W2006996657 cites W2313423582 @default.
- W2006996657 cites W2318772898 @default.
- W2006996657 cites W2530849054 @default.
- W2006996657 doi "https://doi.org/10.1182/blood-2011-04-351924" @default.
- W2006996657 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21816830" @default.
- W2006996657 hasPublicationYear "2011" @default.
- W2006996657 type Work @default.
- W2006996657 sameAs 2006996657 @default.
- W2006996657 citedByCount "113" @default.
- W2006996657 countsByYear W20069966572012 @default.
- W2006996657 countsByYear W20069966572013 @default.
- W2006996657 countsByYear W20069966572014 @default.
- W2006996657 countsByYear W20069966572015 @default.
- W2006996657 countsByYear W20069966572016 @default.
- W2006996657 countsByYear W20069966572017 @default.
- W2006996657 countsByYear W20069966572018 @default.
- W2006996657 countsByYear W20069966572019 @default.
- W2006996657 countsByYear W20069966572020 @default.
- W2006996657 countsByYear W20069966572021 @default.
- W2006996657 countsByYear W20069966572022 @default.
- W2006996657 countsByYear W20069966572023 @default.
- W2006996657 crossrefType "journal-article" @default.
- W2006996657 hasAuthorship W2006996657A5008693201 @default.
- W2006996657 hasAuthorship W2006996657A5012491961 @default.
- W2006996657 hasAuthorship W2006996657A5016570572 @default.
- W2006996657 hasAuthorship W2006996657A5022200573 @default.
- W2006996657 hasAuthorship W2006996657A5028913158 @default.
- W2006996657 hasAuthorship W2006996657A5030759518 @default.
- W2006996657 hasAuthorship W2006996657A5042609656 @default.
- W2006996657 hasAuthorship W2006996657A5045852022 @default.
- W2006996657 hasAuthorship W2006996657A5051903959 @default.
- W2006996657 hasAuthorship W2006996657A5057593886 @default.
- W2006996657 hasAuthorship W2006996657A5061282516 @default.
- W2006996657 hasAuthorship W2006996657A5066257986 @default.
- W2006996657 hasAuthorship W2006996657A5068687462 @default.
- W2006996657 hasAuthorship W2006996657A5070417705 @default.
- W2006996657 hasAuthorship W2006996657A5078922292 @default.